STANDARD BIOTOOLS INC. - COMMON STOCK

Standard BioTools Appoints Alex Kim as Chief Financial Officer

07 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Standard BioTools to Participate in Upcoming Investor Conferences

31 Oct 2024 07:01:00 By Nasdaq GlobeNewswire

Standard BioTools Reports Third Quarter 2024 Financial Results

30 Oct 2024 15:01:01 By Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024

16 Oct 2024 07:00:00 By Nasdaq GlobeNewswire

Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K Platform

24 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH)

18 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

Standard BioTools to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

26 Aug 2024 07:00:00 By Nasdaq GlobeNewswire

Standard BioTools to Participate in Upcoming Investor Conferences

06 Aug 2024 15:01:00 By Nasdaq GlobeNewswire

Standard BioTools Announces Senior Leadership Changes

31 Jul 2024 15:02:00 By Nasdaq GlobeNewswire

Standard BioTools Reports Second Quarter 2024 Financial Results

31 Jul 2024 15:01:00 By Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024

17 Jul 2024 07:01:00 By Nasdaq GlobeNewswire

Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers

28 May 2024 15:01:00 By Nasdaq GlobeNewswire

Standard BioTools to Participate in Upcoming Investor Conferences

22 May 2024 15:01:00 By Nasdaq GlobeNewswire

Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

20 May 2024 07:00:00 By Nasdaq GlobeNewswire

Standard BioTools Reports First Quarter 2024 Financial Results

08 May 2024 15:01:00 By Nasdaq GlobeNewswire

Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth

25 Apr 2024 07:01:00 By Nasdaq GlobeNewswire

Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024

25 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging

08 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research

03 Apr 2024 15:01:13 By Nasdaq GlobeNewswire

Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock

18 Mar 2024 07:12:23 By Nasdaq GlobeNewswire